Centenial Surgical Suture Ltd. has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda of the meeting is to consider and approve the standalone audited financial results for the quarter and year ended March 31, 2026.

Agenda for the Meeting

The board meeting is being convened in accordance with Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The key business to be transacted includes the approval of the standalone audited financial results along with the auditors' report. Additionally, the board may consider any other business with the permission of the chair.

Disclosure of Results

Once approved, the financial results for the specified period will be made available to the public. The company stated that the results will be uploaded on the BSE Limited website immediately following the conclusion of the board meeting.

Centenial Surgical Suture Ltd has submitted its mandatory compliance certificate under SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2026. The filing demonstrates the company's adherence to regulatory requirements governing dematerialisation processes and depositories operations.

Regulatory Compliance Filing

The compliance certificate was filed with BSE Limited on April 16, 2026, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018. Company Secretary and Compliance Officer Mahima Bathwal, bearing membership number ACS A35069, signed and submitted the documentation to the exchange.

Registrar and Transfer Agent Confirmation

Purva Sharegistry (I) Private Limited, serving as the company's registrar and transfer agent, issued the compliance certificate on April 01, 2026. The Mumbai-based firm holds SEBI registration number INR000001112 and operates as a Category 1 registrar for IPOs and share transfer services.

Ms. Deepali Gaonkar, Compliance Officer at Purva Sharegistry, confirmed that all securities received from depository participants for dematerialisation during the quarter were properly processed. The certificate validates that:

• All securities received for dematerialisation were confirmed or rejected to depositories within prescribed timelines
• Security certificates were mutilated and cancelled after due verification by depository participants
• Depository names were substituted in the member register as registered owners
• Securities are listed on stock exchanges where previously issued securities are traded

Corporate Information

Centenial Surgical Suture Ltd operates from its registered office at F-29, MIDC, Murbad, Thane 421401, Maharashtra. The company holds multiple international certifications including ISO 9001:2015, ISO 13485:2016, ISO 14001:2015, ISO 45001:2018, WHO GMP, and CE certification, reflecting its commitment to quality standards in surgical suture manufacturing.

Compliance Framework

The SEBI Regulation 74(5) requires companies to ensure proper handling of dematerialisation requests and maintain accurate records of share transfers. This quarterly compliance certificate serves as a regulatory safeguard, confirming that the company and its registrar have followed prescribed procedures for converting physical share certificates into electronic form and updating ownership records accordingly.